Malmström Erik, Malmström Lars, Hauri Simon, Mohanty Tirthankar, Scott Aaron, Karlsson Christofer, Gueto-Tettay Carlos, Åhrman Emma, Nozohoor Shahab, Tingstedt Bobby, Regner Sara, Elfving Peter, Bjermer Leif, Forsvall Andreas, Doyle Alexander, Magnusson Mattias, Hedenfalk Ingrid, Kannisto Päivi, Brandt Christian, Nilsson Emma, Dahlin Lars B, Malm Johan, Linder Adam, Niméus Emma, Malmström Johan
Division of infection medicine, Department of Clinical Sciences Lund, Lund University, 22184 Lund, Sweden; Emergency Medicine, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Skåne University Hospital, Lund, Sweden; Department of Emergency medicine and Internal medicine, Emergency department, Skåne University Hospital, Lund, Sweden.
Division of infection medicine, Department of Clinical Sciences Lund, Lund University, 22184 Lund, Sweden.
Cell. 2025 May 15;188(10):2810-2822.e16. doi: 10.1016/j.cell.2025.03.013. Epub 2025 Apr 8.
The plasma proteome is maintained by the influx and efflux of proteins from surrounding organs and cells. To quantify the extent to which different organs and cells impact the plasma proteome in healthy and diseased conditions, we developed a mass-spectrometry-based proteomics strategy to infer the tissue origin of proteins detected in human plasma. We first constructed an extensive human proteome atlas from 18 vascularized organs and the 8 most abundant cell types in blood. The atlas was interfaced with previous RNA and protein atlases to objectively define proteome-wide protein-organ associations to infer the origin and enable the reproducible quantification of organ-specific proteins in plasma. We demonstrate that the resource can determine disease-specific quantitative changes of organ-enriched protein panels in six separate patient cohorts, including sepsis, pancreatitis, and myocardial injury. The strategy can be extended to other diseases to advance our understanding of the processes contributing to plasma proteome dynamics.
血浆蛋白质组由来自周围器官和细胞的蛋白质流入和流出维持。为了量化不同器官和细胞在健康和疾病状态下对血浆蛋白质组的影响程度,我们开发了一种基于质谱的蛋白质组学策略,以推断在人血浆中检测到的蛋白质的组织来源。我们首先从18个血管化器官和血液中8种最丰富的细胞类型构建了一个广泛的人类蛋白质组图谱。该图谱与先前的RNA和蛋白质图谱相连接,以客观地定义全蛋白质组范围内的蛋白质-器官关联,从而推断来源并实现血浆中器官特异性蛋白质的可重复定量。我们证明,该资源可以确定六个不同患者队列(包括败血症、胰腺炎和心肌损伤)中器官富集蛋白质组的疾病特异性定量变化。该策略可以扩展到其他疾病,以加深我们对血浆蛋白质组动态变化相关过程的理解。